Astrotech (NASDAQ:ASTC) Stock Passes Above 200 Day Moving Average – Should You Sell?

Astrotech Corporation (NASDAQ:ASTC)’s stock price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $3.58 and traded as high as $5.60. Astrotech shares last traded at $5.23, with a volume of 4,669,571 shares traded.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Astrotech in a report on Friday, March 27th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

Astrotech Stock Down 10.6%

The stock’s 50 day moving average is $2.92 and its 200-day moving average is $3.58. The company has a market cap of $7.00 million, a PE ratio of -0.48 and a beta of -0.12.

Astrotech (NASDAQ:ASTC) last posted its earnings results on Friday, February 13th. The aerospace company reported ($2.34) earnings per share for the quarter. The business had revenue of $0.15 million during the quarter. Astrotech had a negative return on equity of 68.53% and a negative net margin of 1,163.89%.

Institutional Investors Weigh In On Astrotech

An institutional investor recently bought a new position in Astrotech stock. Susquehanna International Group LLP acquired a new stake in Astrotech Corporation (NASDAQ:ASTC) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 13,539 shares of the aerospace company’s stock, valued at approximately $66,000. Susquehanna International Group LLP owned about 0.77% of Astrotech at the end of the most recent reporting period. 24.35% of the stock is owned by hedge funds and other institutional investors.

About Astrotech

Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.

In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.